Siemens Nets FDA Nod for Amyloid Software; Launches Low-Dose CT Option

Siemens Molecular Imaging announced that its syngo.PET Amyloid Plaque neurology quantification software for use in Alzheimer’s disease imaging has been cleared by the FDA. Also, Siemens Molecular Imaging’s preclinical team launched a low-dose CT option for Inveon CT.
Molecular Imaging